2012-09-27 11:23:53 - Globally, the US represents a high potential market for advanced insulin delivery systems, says RNCOS in its latest research report.

With a large diabetic population, US represent the largest market for insulin delivery systems and continue to show great growth potential. Amongst the various insulin systems, insulin pumps have the largest market in the US. Insulin pumps are expected to continue growing in the US on account of flexibility and precision in controlling diabetes that these offer. Insulin syringes also have a dominant share in the insulin delivery systems in US owing to their traditional usage. Insulin pens, on the other hand, are still catching up pace in the US. As per the findings of a new research report by RNCOS, Jet injectors are expected to grow highly in the future and witness a CAGR of around 12.9% during 2012-2015.

Insulin

delivery systems are growing in the market primarily due to changed consumer preferences towards convenient and painless blood glucose testing methodologies. The access of robust technologies has increased greatly with greater consumer awareness driving the market. The Asian markets in particular have shown high acceptance for insulin delivery systems and with some of the highest diabetic countries in Asia, such technologies are expected to capture high market shares.

According to a latest research report by RNCOS, “Insulin Delivery Systems Market Forecast to 2014”, the scope for innovation in creating more efficient insulin delivery systems is high and several promising systems, such as implantable insulin pumps, insulin tablets, inhalers and vaccine etc are being developed in the market. In the global market, geographies, such as China, India, the US, Brazil and Bangladesh are expected to become the top diabetic nations by 2030 and represent the most promising markets for innovators. Market leaders in the field are constantly innovating and launching new products to address consumer needs. The market has also seen strategic activities in recent times.

The 90-page report provides an in-depth research and rational analysis of the current status and expected position of the insulin delivery system market. The study presents a global picture about prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections. As innovation has huge scope in this field, the report elaborates some emerging insulin delivery devices. With a view to providing a complete understanding of the market to clients, the report also discusses profiles of leading market players.

For FREE SAMPLE of this report visit: www.rncos.com/Report/IM369.htm

Some of our Related Reports are:

- US Personalized Cancer Genome Sequencing Market ( www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth ( www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight ( www.rncos.com/Report/IM450.htm)
- US Cardiac Device Market Analysis ( www.rncos.com/Report/IM441.htm)
- US Clinical Laboratory Testing Market Assessment ( www.rncos.com/Report/IM442.htm)

Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.